| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | Director | Common Stock | 3,091,604 | $6,121,375 | $1.98 | 20 Jan 2026 | Direct |
| ImmunityBio, Inc. | Director | Restricted Stock Units | 30,488 | $60,927 | $2.00 | 22 Feb 2025 | Direct |
| Viracta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50,000 | 20 Jun 2024 | Direct | ||
| ImmunityBio, Inc. | Director | Stock Option (right to buy) | 0 | 22 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | 20 Jan 2026 | 2 | -$1,094,297 | 4 | Director | 21 Jan 2026, 20:34 |
| IBRX | ImmunityBio, Inc. | 22 Feb 2025 | 3 | -$18,649 | 4 | Director | 25 Feb 2025, 21:11 |
| IBRX | ImmunityBio, Inc. | 22 Jan 2025 | 2 | +$219,864 | 4 | Director | 24 Jan 2025, 20:47 |
| VIRX | Viracta Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 24 Jun 2024, 19:44 |
| IBRX | ImmunityBio, Inc. | 22 Feb 2024 | 2 | $0 | 4 | Director | 26 Feb 2024, 16:43 |
| IBRX | ImmunityBio, Inc. | 31 Jan 2024 | 3 | -$74,236 | 4 | Director | 02 Feb 2024, 19:38 |
| IBRX | ImmunityBio, Inc. | 01 Sep 2023 | 2 | $0 | 4 | Director | 06 Sep 2023, 19:39 |
| IBRX | ImmunityBio, Inc. | 25 Aug 2023 | 1 | $0 | 4 | Director | 28 Aug 2023, 21:01 |
| VIRX | Viracta Therapeutics, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 18:49 |
| VIRX | Viracta Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 17:16 |
| IBRX | ImmunityBio, Inc. | 23 Mar 2022 | 1 | $0 | 4 | Director | 25 Mar 2022, 21:05 |
| IBRX | ImmunityBio, Inc. | 31 Dec 2021 | 1 | $0 | 5 | Director | 28 Jan 2022, 15:28 |
| IBRX | ImmunityBio, Inc. | 21 May 2021 | 3 | -$2,018,057 | 4 | Director | 25 May 2021, 20:00 |
| IBRX | ImmunityBio, Inc. | 05 May 2021 | 2 | +$99,943 | 4 | Director | 07 May 2021, 16:09 |